Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
Aldeyra Therapeutics (ALDX) Stock Price & Analysis
1,228 Followers
ALDX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.36 - $7.99
Previous Close$6.09
Volume363.60K
Average Volume (3M)339.86K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$185.33M
Total Debt (Recent Filing)$15.94M
Price to Earnings (P/E)-5.5
Beta0.34
Next EarningsMar 30, 2023
EPS Estimate-$0.31
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$17.75
EPS (TTM)-1.11
Shares Outstanding58,560,078
R-Squared0.07
Standard Deviation0.23
10 Day Avg. Volume372,247
30 Day Avg. Volume339,863
Price to Book (P/B)2.20
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-7.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside191.46% Upside
Rating ConsensusStrong Buy
Alpha0.02
Number of Analyst Covering4
Aldeyra Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ALDX FAQ
What was Aldeyra Therapeutics’s price range in the past 12 months?
Aldeyra Therapeutics lowest stock price was $2.35 and its highest was $7.99 in the past 12 months.
What is Aldeyra Therapeutics’s market cap?
Currently, no data Available
When is Aldeyra Therapeutics’s upcoming earnings report date?
Aldeyra Therapeutics’s upcoming earnings report date is Mar 30, 2023 which is in 60 days.
How were Aldeyra Therapeutics’s earnings last quarter?
Aldeyra Therapeutics released its earnings results on Nov 10, 2022. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.344 by $0.094.
Is Aldeyra Therapeutics overvalued?
According to Wall Street analysts Aldeyra Therapeutics’s price is currently Undervalued.
Does Aldeyra Therapeutics pay dividends?
Aldeyra Therapeutics does not currently pay dividends.
What is Aldeyra Therapeutics’s EPS estimate?
Aldeyra Therapeutics’s EPS estimate is -$0.31.
How many shares outstanding does Aldeyra Therapeutics have?
Aldeyra Therapeutics has 58,560,078 shares outstanding.
What happened to Aldeyra Therapeutics’s price movement after its last earnings report?
Aldeyra Therapeutics reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.344. Following the earnings report the stock price went up 6.178%.
Which hedge fund is a major shareholder of Aldeyra Therapeutics?
Among the largest hedge funds holding Aldeyra Therapeutics’s share is Perceptive Advisors LLC. It holds Aldeyra Therapeutics’s shares valued at 61M.
---
Aldeyra Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$17.75
$17.75
Blogger Sentiment
Bullish
ALDX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
86.80%
12-Months-Change
Fundamentals
Return on Equity
-33.98%
Trailing 12-Months
Asset Growth
-23.27%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Aldeyra Therapeutics
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
---
---